nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT1A1—lung cancer	0.234	0.676	CbGaD
Losartan—ALB—lung cancer	0.0574	0.166	CbGaD
Losartan—ABCB1—lung cancer	0.0547	0.158	CbGaD
Losartan—SLCO1B3—Paclitaxel—lung cancer	0.0254	0.0617	CbGbCtD
Losartan—UGT1A1—Erlotinib—lung cancer	0.0233	0.0567	CbGbCtD
Losartan—UGT1A1—Irinotecan—lung cancer	0.0211	0.0512	CbGbCtD
Losartan—SLCO1B3—Docetaxel—lung cancer	0.0184	0.0446	CbGbCtD
Losartan—UGT1A1—Etoposide—lung cancer	0.0169	0.041	CbGbCtD
Losartan—ALB—Gefitinib—lung cancer	0.015	0.0364	CbGbCtD
Losartan—SLCO1B1—Irinotecan—lung cancer	0.0146	0.0355	CbGbCtD
Losartan—SLCO1B3—Methotrexate—lung cancer	0.0133	0.0322	CbGbCtD
Losartan—CYP3A5—Gefitinib—lung cancer	0.012	0.0292	CbGbCtD
Losartan—CYP3A5—Teniposide—lung cancer	0.0117	0.0283	CbGbCtD
Losartan—CYP2C19—Gefitinib—lung cancer	0.0097	0.0236	CbGbCtD
Losartan—CYP2C19—Teniposide—lung cancer	0.00941	0.0229	CbGbCtD
Losartan—ALB—Erlotinib—lung cancer	0.00885	0.0215	CbGbCtD
Losartan—ABCB1—Topotecan—lung cancer	0.00856	0.0208	CbGbCtD
Losartan—CYP2C9—Gefitinib—lung cancer	0.00807	0.0196	CbGbCtD
Losartan—ALB—Irinotecan—lung cancer	0.00799	0.0194	CbGbCtD
Losartan—ABCB1—Gefitinib—lung cancer	0.00783	0.019	CbGbCtD
Losartan—CYP2C9—Teniposide—lung cancer	0.00782	0.019	CbGbCtD
Losartan—SLCO1B1—Methotrexate—lung cancer	0.00772	0.0188	CbGbCtD
Losartan—CYP3A5—Crizotinib—lung cancer	0.00737	0.0179	CbGbCtD
Losartan—CYP3A5—Erlotinib—lung cancer	0.00711	0.0173	CbGbCtD
Losartan—CYP2C8—Erlotinib—lung cancer	0.00684	0.0166	CbGbCtD
Losartan—CYP3A5—Paclitaxel—lung cancer	0.00651	0.0158	CbGbCtD
Losartan—CYP3A5—Irinotecan—lung cancer	0.00642	0.0156	CbGbCtD
Losartan—CYP2C8—Paclitaxel—lung cancer	0.00626	0.0152	CbGbCtD
Losartan—ABCB1—Vinorelbine—lung cancer	0.00603	0.0147	CbGbCtD
Losartan—CYP1A2—Erlotinib—lung cancer	0.00529	0.0129	CbGbCtD
Losartan—CYP3A5—Etoposide—lung cancer	0.00514	0.0125	CbGbCtD
Losartan—CYP3A4—Topotecan—lung cancer	0.00513	0.0125	CbGbCtD
Losartan—SLC22A6—Methotrexate—lung cancer	0.00496	0.0121	CbGbCtD
Losartan—CYP2C8—Etoposide—lung cancer	0.00495	0.012	CbGbCtD
Losartan—ABCB1—Crizotinib—lung cancer	0.0048	0.0117	CbGbCtD
Losartan—CYP3A5—Docetaxel—lung cancer	0.00471	0.0114	CbGbCtD
Losartan—CYP3A4—Gefitinib—lung cancer	0.00469	0.0114	CbGbCtD
Losartan—ABCB1—Gemcitabine—lung cancer	0.00469	0.0114	CbGbCtD
Losartan—ABCB1—Erlotinib—lung cancer	0.00463	0.0112	CbGbCtD
Losartan—CYP3A4—Teniposide—lung cancer	0.00455	0.011	CbGbCtD
Losartan—CYP2C9—Paclitaxel—lung cancer	0.00437	0.0106	CbGbCtD
Losartan—ABCB1—Paclitaxel—lung cancer	0.00424	0.0103	CbGbCtD
Losartan—ALB—Methotrexate—lung cancer	0.00423	0.0103	CbGbCtD
Losartan—ABCB1—Irinotecan—lung cancer	0.00418	0.0102	CbGbCtD
Losartan—CYP1A2—Etoposide—lung cancer	0.00383	0.0093	CbGbCtD
Losartan—ABCB1—Vinblastine—lung cancer	0.00372	0.00903	CbGbCtD
Losartan—CYP3A4—Vinorelbine—lung cancer	0.00361	0.00878	CbGbCtD
Losartan—CYP2C9—Cisplatin—lung cancer	0.00351	0.00853	CbGbCtD
Losartan—ABCB1—Cisplatin—lung cancer	0.00341	0.00828	CbGbCtD
Losartan—UGT2B17—epithelium—lung cancer	0.00338	0.158	CbGeAlD
Losartan—ABCB1—Etoposide—lung cancer	0.00335	0.00813	CbGbCtD
Losartan—ABCB1—Docetaxel—lung cancer	0.00306	0.00744	CbGbCtD
Losartan—ACE—pulmonary artery—lung cancer	0.00301	0.141	CbGeAlD
Losartan—CYP3A4—Crizotinib—lung cancer	0.00287	0.00698	CbGbCtD
Losartan—CYP3A4—Erlotinib—lung cancer	0.00277	0.00674	CbGbCtD
Losartan—CYP3A4—Paclitaxel—lung cancer	0.00254	0.00617	CbGbCtD
Losartan—CYP3A4—Irinotecan—lung cancer	0.0025	0.00608	CbGbCtD
Losartan—ABCB1—Doxorubicin—lung cancer	0.00228	0.00555	CbGbCtD
Losartan—CYP3A4—Vinblastine—lung cancer	0.00223	0.00541	CbGbCtD
Losartan—ABCB1—Methotrexate—lung cancer	0.00221	0.00537	CbGbCtD
Losartan—CYP3A4—Etoposide—lung cancer	0.00201	0.00487	CbGbCtD
Losartan—ACE—umbilical vein—lung cancer	0.00199	0.0931	CbGeAlD
Losartan—CYP3A4—Docetaxel—lung cancer	0.00184	0.00446	CbGbCtD
Losartan—SLC2A9—respiratory system—lung cancer	0.00179	0.0838	CbGeAlD
Losartan—CYP3A4—Doxorubicin—lung cancer	0.00137	0.00332	CbGbCtD
Losartan—Irbesartan—JUN—lung cancer	0.0011	0.519	CrCbGaD
Losartan—SLCO1B1—mammary gland—lung cancer	0.000981	0.0459	CbGeAlD
Losartan—SLC2A9—lung—lung cancer	0.00095	0.0445	CbGeAlD
Losartan—ALB—mammary gland—lung cancer	0.000793	0.0372	CbGeAlD
Losartan—SLC2A9—lymph node—lung cancer	0.00065	0.0304	CbGeAlD
Losartan—SLCO1B3—lung—lung cancer	0.0006	0.0281	CbGeAlD
Losartan—AGTR1—epithelium—lung cancer	0.000573	0.0268	CbGeAlD
Losartan—CYP2C8—mammary gland—lung cancer	0.000558	0.0261	CbGeAlD
Losartan—AGTR1—trachea—lung cancer	0.000506	0.0237	CbGeAlD
Losartan—ACE—respiratory system—lung cancer	0.000506	0.0237	CbGeAlD
Losartan—CYP2C9—mammary gland—lung cancer	0.000495	0.0232	CbGeAlD
Losartan—AGTR1—cardiac atrium—lung cancer	0.000476	0.0223	CbGeAlD
Losartan—Telmisartan—ABCG2—lung cancer	0.00046	0.217	CrCbGaD
Losartan—ACE—epithelium—lung cancer	0.000423	0.0198	CbGeAlD
Losartan—AGTR1—lung—lung cancer	0.000364	0.0171	CbGeAlD
Losartan—ACE—cardiac atrium—lung cancer	0.000351	0.0165	CbGeAlD
Losartan—CYP1A2—respiratory system—lung cancer	0.000348	0.0163	CbGeAlD
Losartan—CYP3A5—respiratory system—lung cancer	0.000335	0.0157	CbGeAlD
Losartan—ACE—bone marrow—lung cancer	0.000297	0.0139	CbGeAlD
Losartan—ACE—lung—lung cancer	0.000269	0.0126	CbGeAlD
Losartan—AGTR1—lymph node—lung cancer	0.000249	0.0117	CbGeAlD
Losartan—Valsartan—ALB—lung cancer	0.000213	0.101	CrCbGaD
Losartan—ALB—lymph node—lung cancer	0.000192	0.009	CbGeAlD
Losartan—Telmisartan—ABCB1—lung cancer	0.000191	0.0903	CrCbGaD
Losartan—CYP1A2—lung—lung cancer	0.000185	0.00865	CbGeAlD
Losartan—ACE—lymph node—lung cancer	0.000184	0.00861	CbGeAlD
Losartan—ABCB1—respiratory system—lung cancer	0.000178	0.00835	CbGeAlD
Losartan—CYP3A5—lung—lung cancer	0.000178	0.00834	CbGeAlD
Losartan—Candesartan—ABCB1—lung cancer	0.000154	0.0728	CrCbGaD
Losartan—ABCB1—epithelium—lung cancer	0.000149	0.00698	CbGeAlD
Losartan—ABCB1—trachea—lung cancer	0.000132	0.00617	CbGeAlD
Losartan—ABCB1—bone marrow—lung cancer	0.000104	0.00489	CbGeAlD
Losartan—ABCB1—lung—lung cancer	9.46e-05	0.00443	CbGeAlD
Losartan—ABCB1—lymph node—lung cancer	6.47e-05	0.00303	CbGeAlD
Losartan—Cough—Docetaxel—lung cancer	5.92e-05	0.000527	CcSEcCtD
Losartan—Angina pectoris—Doxorubicin—lung cancer	5.92e-05	0.000527	CcSEcCtD
Losartan—Insomnia—Paclitaxel—lung cancer	5.9e-05	0.000526	CcSEcCtD
Losartan—Epistaxis—Methotrexate—lung cancer	5.9e-05	0.000525	CcSEcCtD
Losartan—Hypersensitivity—Irinotecan—lung cancer	5.9e-05	0.000525	CcSEcCtD
Losartan—Paraesthesia—Paclitaxel—lung cancer	5.86e-05	0.000522	CcSEcCtD
Losartan—Bronchitis—Doxorubicin—lung cancer	5.84e-05	0.00052	CcSEcCtD
Losartan—Agranulocytosis—Methotrexate—lung cancer	5.84e-05	0.00052	CcSEcCtD
Losartan—Dyspnoea—Paclitaxel—lung cancer	5.82e-05	0.000518	CcSEcCtD
Losartan—Somnolence—Paclitaxel—lung cancer	5.8e-05	0.000517	CcSEcCtD
Losartan—Decreased appetite—Etoposide—lung cancer	5.79e-05	0.000516	CcSEcCtD
Losartan—Arthralgia—Docetaxel—lung cancer	5.77e-05	0.000514	CcSEcCtD
Losartan—Myalgia—Docetaxel—lung cancer	5.77e-05	0.000514	CcSEcCtD
Losartan—Chest pain—Docetaxel—lung cancer	5.77e-05	0.000514	CcSEcCtD
Losartan—Nausea—Vinorelbine—lung cancer	5.77e-05	0.000514	CcSEcCtD
Losartan—Dyspepsia—Paclitaxel—lung cancer	5.75e-05	0.000512	CcSEcCtD
Losartan—Body temperature increased—Cisplatin—lung cancer	5.75e-05	0.000512	CcSEcCtD
Losartan—Asthenia—Irinotecan—lung cancer	5.74e-05	0.000512	CcSEcCtD
Losartan—Fatigue—Etoposide—lung cancer	5.74e-05	0.000511	CcSEcCtD
Losartan—Pain—Etoposide—lung cancer	5.69e-05	0.000507	CcSEcCtD
Losartan—Constipation—Etoposide—lung cancer	5.69e-05	0.000507	CcSEcCtD
Losartan—Decreased appetite—Paclitaxel—lung cancer	5.68e-05	0.000506	CcSEcCtD
Losartan—Dry mouth—Docetaxel—lung cancer	5.65e-05	0.000503	CcSEcCtD
Losartan—Upper respiratory tract infection—Doxorubicin—lung cancer	5.64e-05	0.000503	CcSEcCtD
Losartan—Fatigue—Paclitaxel—lung cancer	5.63e-05	0.000501	CcSEcCtD
Losartan—Hepatitis—Methotrexate—lung cancer	5.61e-05	0.0005	CcSEcCtD
Losartan—Pollakiuria—Doxorubicin—lung cancer	5.61e-05	0.0005	CcSEcCtD
Losartan—Asthenia—Gemcitabine—lung cancer	5.59e-05	0.000498	CcSEcCtD
Losartan—Constipation—Paclitaxel—lung cancer	5.58e-05	0.000497	CcSEcCtD
Losartan—Pain—Paclitaxel—lung cancer	5.58e-05	0.000497	CcSEcCtD
Losartan—Confusional state—Docetaxel—lung cancer	5.58e-05	0.000497	CcSEcCtD
Losartan—Pharyngitis—Methotrexate—lung cancer	5.57e-05	0.000496	CcSEcCtD
Losartan—Photosensitivity reaction—Doxorubicin—lung cancer	5.54e-05	0.000494	CcSEcCtD
Losartan—Oedema—Docetaxel—lung cancer	5.53e-05	0.000493	CcSEcCtD
Losartan—Anaphylactic shock—Docetaxel—lung cancer	5.53e-05	0.000493	CcSEcCtD
Losartan—Weight increased—Doxorubicin—lung cancer	5.53e-05	0.000492	CcSEcCtD
Losartan—Pruritus—Gemcitabine—lung cancer	5.52e-05	0.000491	CcSEcCtD
Losartan—Infection—Docetaxel—lung cancer	5.5e-05	0.00049	CcSEcCtD
Losartan—Feeling abnormal—Etoposide—lung cancer	5.49e-05	0.000489	CcSEcCtD
Losartan—Hyperglycaemia—Doxorubicin—lung cancer	5.48e-05	0.000488	CcSEcCtD
Losartan—Diarrhoea—Irinotecan—lung cancer	5.48e-05	0.000488	CcSEcCtD
Losartan—Pneumonia—Doxorubicin—lung cancer	5.45e-05	0.000485	CcSEcCtD
Losartan—Gastrointestinal pain—Etoposide—lung cancer	5.44e-05	0.000485	CcSEcCtD
Losartan—Shock—Docetaxel—lung cancer	5.44e-05	0.000485	CcSEcCtD
Losartan—Nervous system disorder—Docetaxel—lung cancer	5.43e-05	0.000483	CcSEcCtD
Losartan—Thrombocytopenia—Docetaxel—lung cancer	5.42e-05	0.000483	CcSEcCtD
Losartan—Tachycardia—Docetaxel—lung cancer	5.4e-05	0.000481	CcSEcCtD
Losartan—Feeling abnormal—Paclitaxel—lung cancer	5.38e-05	0.000479	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Doxorubicin—lung cancer	5.37e-05	0.000478	CcSEcCtD
Losartan—Hypersensitivity—Cisplatin—lung cancer	5.35e-05	0.000477	CcSEcCtD
Losartan—Gastrointestinal pain—Paclitaxel—lung cancer	5.34e-05	0.000476	CcSEcCtD
Losartan—Diarrhoea—Gemcitabine—lung cancer	5.34e-05	0.000475	CcSEcCtD
Losartan—Renal failure—Doxorubicin—lung cancer	5.32e-05	0.000474	CcSEcCtD
Losartan—Erythema multiforme—Methotrexate—lung cancer	5.31e-05	0.000473	CcSEcCtD
Losartan—Neuropathy peripheral—Doxorubicin—lung cancer	5.31e-05	0.000473	CcSEcCtD
Losartan—Dizziness—Irinotecan—lung cancer	5.29e-05	0.000472	CcSEcCtD
Losartan—Urticaria—Etoposide—lung cancer	5.29e-05	0.000471	CcSEcCtD
Losartan—Jaundice—Doxorubicin—lung cancer	5.28e-05	0.00047	CcSEcCtD
Losartan—Anorexia—Docetaxel—lung cancer	5.27e-05	0.00047	CcSEcCtD
Losartan—Abdominal pain—Etoposide—lung cancer	5.26e-05	0.000469	CcSEcCtD
Losartan—Body temperature increased—Etoposide—lung cancer	5.26e-05	0.000469	CcSEcCtD
Losartan—Conjunctivitis—Doxorubicin—lung cancer	5.26e-05	0.000469	CcSEcCtD
Losartan—Urinary tract infection—Doxorubicin—lung cancer	5.26e-05	0.000469	CcSEcCtD
Losartan—Tinnitus—Methotrexate—lung cancer	5.23e-05	0.000466	CcSEcCtD
Losartan—Asthenia—Cisplatin—lung cancer	5.21e-05	0.000465	CcSEcCtD
Losartan—Sweating—Doxorubicin—lung cancer	5.19e-05	0.000462	CcSEcCtD
Losartan—Urticaria—Paclitaxel—lung cancer	5.19e-05	0.000462	CcSEcCtD
Losartan—Hypotension—Docetaxel—lung cancer	5.17e-05	0.000461	CcSEcCtD
Losartan—Body temperature increased—Paclitaxel—lung cancer	5.16e-05	0.00046	CcSEcCtD
Losartan—Abdominal pain—Paclitaxel—lung cancer	5.16e-05	0.00046	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—lung cancer	5.11e-05	0.000455	CcSEcCtD
Losartan—Angiopathy—Methotrexate—lung cancer	5.09e-05	0.000454	CcSEcCtD
Losartan—Vomiting—Irinotecan—lung cancer	5.09e-05	0.000453	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—lung cancer	5.08e-05	0.000453	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—lung cancer	5.05e-05	0.00045	CcSEcCtD
Losartan—Rash—Irinotecan—lung cancer	5.05e-05	0.00045	CcSEcCtD
Losartan—Dermatitis—Irinotecan—lung cancer	5.04e-05	0.000449	CcSEcCtD
Losartan—Musculoskeletal discomfort—Docetaxel—lung cancer	5.04e-05	0.000449	CcSEcCtD
Losartan—Headache—Irinotecan—lung cancer	5.01e-05	0.000447	CcSEcCtD
Losartan—Insomnia—Docetaxel—lung cancer	5.01e-05	0.000446	CcSEcCtD
Losartan—Diarrhoea—Cisplatin—lung cancer	4.97e-05	0.000443	CcSEcCtD
Losartan—Paraesthesia—Docetaxel—lung cancer	4.97e-05	0.000443	CcSEcCtD
Losartan—Alopecia—Methotrexate—lung cancer	4.96e-05	0.000442	CcSEcCtD
Losartan—Vomiting—Gemcitabine—lung cancer	4.96e-05	0.000442	CcSEcCtD
Losartan—Dyspnoea—Docetaxel—lung cancer	4.93e-05	0.000439	CcSEcCtD
Losartan—Somnolence—Docetaxel—lung cancer	4.92e-05	0.000438	CcSEcCtD
Losartan—Rash—Gemcitabine—lung cancer	4.92e-05	0.000438	CcSEcCtD
Losartan—Dermatitis—Gemcitabine—lung cancer	4.91e-05	0.000438	CcSEcCtD
Losartan—Hypersensitivity—Etoposide—lung cancer	4.91e-05	0.000437	CcSEcCtD
Losartan—Erythema—Methotrexate—lung cancer	4.89e-05	0.000435	CcSEcCtD
Losartan—Headache—Gemcitabine—lung cancer	4.89e-05	0.000435	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—lung cancer	4.87e-05	0.000434	CcSEcCtD
Losartan—Dyspepsia—Docetaxel—lung cancer	4.87e-05	0.000434	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—lung cancer	4.86e-05	0.000433	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—lung cancer	4.84e-05	0.000431	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—lung cancer	4.82e-05	0.00043	CcSEcCtD
Losartan—Decreased appetite—Docetaxel—lung cancer	4.81e-05	0.000428	CcSEcCtD
Losartan—Hypersensitivity—Paclitaxel—lung cancer	4.81e-05	0.000428	CcSEcCtD
Losartan—Dysgeusia—Methotrexate—lung cancer	4.79e-05	0.000426	CcSEcCtD
Losartan—Asthenia—Etoposide—lung cancer	4.78e-05	0.000426	CcSEcCtD
Losartan—Fatigue—Docetaxel—lung cancer	4.77e-05	0.000425	CcSEcCtD
Losartan—Nausea—Irinotecan—lung cancer	4.75e-05	0.000424	CcSEcCtD
Losartan—Constipation—Docetaxel—lung cancer	4.73e-05	0.000422	CcSEcCtD
Losartan—Pain—Docetaxel—lung cancer	4.73e-05	0.000422	CcSEcCtD
Losartan—Back pain—Methotrexate—lung cancer	4.73e-05	0.000421	CcSEcCtD
Losartan—Pruritus—Etoposide—lung cancer	4.71e-05	0.00042	CcSEcCtD
Losartan—Asthenia—Paclitaxel—lung cancer	4.68e-05	0.000417	CcSEcCtD
Losartan—Nausea—Gemcitabine—lung cancer	4.63e-05	0.000413	CcSEcCtD
Losartan—Vomiting—Cisplatin—lung cancer	4.62e-05	0.000412	CcSEcCtD
Losartan—Pruritus—Paclitaxel—lung cancer	4.62e-05	0.000411	CcSEcCtD
Losartan—Vision blurred—Methotrexate—lung cancer	4.61e-05	0.00041	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—lung cancer	4.6e-05	0.000409	CcSEcCtD
Losartan—Rash—Cisplatin—lung cancer	4.58e-05	0.000408	CcSEcCtD
Losartan—Dermatitis—Cisplatin—lung cancer	4.58e-05	0.000408	CcSEcCtD
Losartan—Feeling abnormal—Docetaxel—lung cancer	4.56e-05	0.000406	CcSEcCtD
Losartan—Diarrhoea—Etoposide—lung cancer	4.56e-05	0.000406	CcSEcCtD
Losartan—Ill-defined disorder—Methotrexate—lung cancer	4.53e-05	0.000404	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—lung cancer	4.53e-05	0.000404	CcSEcCtD
Losartan—Gastrointestinal pain—Docetaxel—lung cancer	4.53e-05	0.000403	CcSEcCtD
Losartan—Anaemia—Methotrexate—lung cancer	4.52e-05	0.000402	CcSEcCtD
Losartan—Flushing—Doxorubicin—lung cancer	4.51e-05	0.000402	CcSEcCtD
Losartan—Diarrhoea—Paclitaxel—lung cancer	4.47e-05	0.000398	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—lung cancer	4.41e-05	0.000393	CcSEcCtD
Losartan—Malaise—Methotrexate—lung cancer	4.41e-05	0.000393	CcSEcCtD
Losartan—Dizziness—Etoposide—lung cancer	4.4e-05	0.000392	CcSEcCtD
Losartan—Vertigo—Methotrexate—lung cancer	4.39e-05	0.000391	CcSEcCtD
Losartan—Abdominal pain—Docetaxel—lung cancer	4.37e-05	0.00039	CcSEcCtD
Losartan—Body temperature increased—Docetaxel—lung cancer	4.37e-05	0.00039	CcSEcCtD
Losartan—Leukopenia—Methotrexate—lung cancer	4.37e-05	0.00039	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—lung cancer	4.34e-05	0.000387	CcSEcCtD
Losartan—Dizziness—Paclitaxel—lung cancer	4.32e-05	0.000385	CcSEcCtD
Losartan—Nausea—Cisplatin—lung cancer	4.32e-05	0.000385	CcSEcCtD
Losartan—Alopecia—Doxorubicin—lung cancer	4.3e-05	0.000383	CcSEcCtD
Losartan—Cough—Methotrexate—lung cancer	4.26e-05	0.00038	CcSEcCtD
Losartan—Vomiting—Etoposide—lung cancer	4.23e-05	0.000377	CcSEcCtD
Losartan—Erythema—Doxorubicin—lung cancer	4.23e-05	0.000377	CcSEcCtD
Losartan—Rash—Etoposide—lung cancer	4.2e-05	0.000374	CcSEcCtD
Losartan—Dermatitis—Etoposide—lung cancer	4.19e-05	0.000374	CcSEcCtD
Losartan—Headache—Etoposide—lung cancer	4.17e-05	0.000372	CcSEcCtD
Losartan—Flatulence—Doxorubicin—lung cancer	4.17e-05	0.000371	CcSEcCtD
Losartan—Chest pain—Methotrexate—lung cancer	4.16e-05	0.000371	CcSEcCtD
Losartan—Myalgia—Methotrexate—lung cancer	4.16e-05	0.000371	CcSEcCtD
Losartan—Arthralgia—Methotrexate—lung cancer	4.16e-05	0.000371	CcSEcCtD
Losartan—Tension—Doxorubicin—lung cancer	4.15e-05	0.00037	CcSEcCtD
Losartan—Vomiting—Paclitaxel—lung cancer	4.15e-05	0.00037	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—lung cancer	4.14e-05	0.000369	CcSEcCtD
Losartan—Rash—Paclitaxel—lung cancer	4.12e-05	0.000367	CcSEcCtD
Losartan—Dermatitis—Paclitaxel—lung cancer	4.11e-05	0.000366	CcSEcCtD
Losartan—Discomfort—Methotrexate—lung cancer	4.11e-05	0.000366	CcSEcCtD
Losartan—Nervousness—Doxorubicin—lung cancer	4.11e-05	0.000366	CcSEcCtD
Losartan—Back pain—Doxorubicin—lung cancer	4.09e-05	0.000365	CcSEcCtD
Losartan—Headache—Paclitaxel—lung cancer	4.09e-05	0.000364	CcSEcCtD
Losartan—Hypersensitivity—Docetaxel—lung cancer	4.08e-05	0.000363	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—lung cancer	4.07e-05	0.000362	CcSEcCtD
Losartan—Confusional state—Methotrexate—lung cancer	4.02e-05	0.000358	CcSEcCtD
Losartan—Anaphylactic shock—Methotrexate—lung cancer	3.99e-05	0.000355	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—lung cancer	3.99e-05	0.000355	CcSEcCtD
Losartan—Asthenia—Docetaxel—lung cancer	3.97e-05	0.000354	CcSEcCtD
Losartan—Infection—Methotrexate—lung cancer	3.96e-05	0.000353	CcSEcCtD
Losartan—Nausea—Etoposide—lung cancer	3.96e-05	0.000352	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—lung cancer	3.93e-05	0.00035	CcSEcCtD
Losartan—Pruritus—Docetaxel—lung cancer	3.92e-05	0.000349	CcSEcCtD
Losartan—Nervous system disorder—Methotrexate—lung cancer	3.91e-05	0.000348	CcSEcCtD
Losartan—Anaemia—Doxorubicin—lung cancer	3.91e-05	0.000348	CcSEcCtD
Losartan—Thrombocytopenia—Methotrexate—lung cancer	3.91e-05	0.000348	CcSEcCtD
Losartan—Agitation—Doxorubicin—lung cancer	3.89e-05	0.000346	CcSEcCtD
Losartan—Nausea—Paclitaxel—lung cancer	3.88e-05	0.000345	CcSEcCtD
Losartan—Hyperhidrosis—Methotrexate—lung cancer	3.86e-05	0.000343	CcSEcCtD
Losartan—Malaise—Doxorubicin—lung cancer	3.82e-05	0.00034	CcSEcCtD
Losartan—Vertigo—Doxorubicin—lung cancer	3.8e-05	0.000339	CcSEcCtD
Losartan—Anorexia—Methotrexate—lung cancer	3.8e-05	0.000339	CcSEcCtD
Losartan—Syncope—Doxorubicin—lung cancer	3.79e-05	0.000338	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—lung cancer	3.79e-05	0.000337	CcSEcCtD
Losartan—Diarrhoea—Docetaxel—lung cancer	3.79e-05	0.000337	CcSEcCtD
Losartan—Palpitations—Doxorubicin—lung cancer	3.74e-05	0.000333	CcSEcCtD
Losartan—Hypotension—Methotrexate—lung cancer	3.73e-05	0.000332	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—lung cancer	3.72e-05	0.000331	CcSEcCtD
Losartan—Cough—Doxorubicin—lung cancer	3.69e-05	0.000329	CcSEcCtD
Losartan—Dizziness—Docetaxel—lung cancer	3.66e-05	0.000326	CcSEcCtD
Losartan—Musculoskeletal discomfort—Methotrexate—lung cancer	3.63e-05	0.000324	CcSEcCtD
Losartan—Insomnia—Methotrexate—lung cancer	3.61e-05	0.000321	CcSEcCtD
Losartan—Myalgia—Doxorubicin—lung cancer	3.6e-05	0.000321	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—lung cancer	3.6e-05	0.000321	CcSEcCtD
Losartan—Chest pain—Doxorubicin—lung cancer	3.6e-05	0.000321	CcSEcCtD
Losartan—Anxiety—Doxorubicin—lung cancer	3.59e-05	0.00032	CcSEcCtD
Losartan—Paraesthesia—Methotrexate—lung cancer	3.58e-05	0.000319	CcSEcCtD
Losartan—Discomfort—Doxorubicin—lung cancer	3.56e-05	0.000317	CcSEcCtD
Losartan—Dyspnoea—Methotrexate—lung cancer	3.56e-05	0.000317	CcSEcCtD
Losartan—Somnolence—Methotrexate—lung cancer	3.55e-05	0.000316	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—lung cancer	3.52e-05	0.000314	CcSEcCtD
Losartan—Vomiting—Docetaxel—lung cancer	3.52e-05	0.000313	CcSEcCtD
Losartan—Dyspepsia—Methotrexate—lung cancer	3.51e-05	0.000313	CcSEcCtD
Losartan—Rash—Docetaxel—lung cancer	3.49e-05	0.000311	CcSEcCtD
Losartan—Dermatitis—Docetaxel—lung cancer	3.49e-05	0.000311	CcSEcCtD
Losartan—Confusional state—Doxorubicin—lung cancer	3.48e-05	0.00031	CcSEcCtD
Losartan—Decreased appetite—Methotrexate—lung cancer	3.47e-05	0.000309	CcSEcCtD
Losartan—Headache—Docetaxel—lung cancer	3.47e-05	0.000309	CcSEcCtD
Losartan—Oedema—Doxorubicin—lung cancer	3.45e-05	0.000308	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—lung cancer	3.45e-05	0.000308	CcSEcCtD
Losartan—Fatigue—Methotrexate—lung cancer	3.44e-05	0.000306	CcSEcCtD
Losartan—Infection—Doxorubicin—lung cancer	3.43e-05	0.000306	CcSEcCtD
Losartan—Pain—Methotrexate—lung cancer	3.41e-05	0.000304	CcSEcCtD
Losartan—Shock—Doxorubicin—lung cancer	3.4e-05	0.000303	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—lung cancer	3.39e-05	0.000302	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—lung cancer	3.38e-05	0.000301	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—lung cancer	3.37e-05	0.0003	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—lung cancer	3.34e-05	0.000297	CcSEcCtD
Losartan—Anorexia—Doxorubicin—lung cancer	3.29e-05	0.000293	CcSEcCtD
Losartan—Nausea—Docetaxel—lung cancer	3.29e-05	0.000293	CcSEcCtD
Losartan—Feeling abnormal—Methotrexate—lung cancer	3.29e-05	0.000293	CcSEcCtD
Losartan—Gastrointestinal pain—Methotrexate—lung cancer	3.26e-05	0.000291	CcSEcCtD
Losartan—Hypotension—Doxorubicin—lung cancer	3.23e-05	0.000287	CcSEcCtD
Losartan—Urticaria—Methotrexate—lung cancer	3.17e-05	0.000282	CcSEcCtD
Losartan—Body temperature increased—Methotrexate—lung cancer	3.15e-05	0.000281	CcSEcCtD
Losartan—Abdominal pain—Methotrexate—lung cancer	3.15e-05	0.000281	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.15e-05	0.00028	CcSEcCtD
Losartan—Insomnia—Doxorubicin—lung cancer	3.12e-05	0.000278	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—lung cancer	3.1e-05	0.000276	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—lung cancer	3.08e-05	0.000274	CcSEcCtD
Losartan—Somnolence—Doxorubicin—lung cancer	3.07e-05	0.000273	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—lung cancer	3.04e-05	0.000271	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—lung cancer	3e-05	0.000267	CcSEcCtD
Losartan—Fatigue—Doxorubicin—lung cancer	2.98e-05	0.000265	CcSEcCtD
Losartan—Constipation—Doxorubicin—lung cancer	2.95e-05	0.000263	CcSEcCtD
Losartan—Pain—Doxorubicin—lung cancer	2.95e-05	0.000263	CcSEcCtD
Losartan—Hypersensitivity—Methotrexate—lung cancer	2.94e-05	0.000262	CcSEcCtD
Losartan—Asthenia—Methotrexate—lung cancer	2.86e-05	0.000255	CcSEcCtD
Losartan—Feeling abnormal—Doxorubicin—lung cancer	2.85e-05	0.000254	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—lung cancer	2.82e-05	0.000252	CcSEcCtD
Losartan—Pruritus—Methotrexate—lung cancer	2.82e-05	0.000251	CcSEcCtD
Losartan—Urticaria—Doxorubicin—lung cancer	2.74e-05	0.000244	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—lung cancer	2.73e-05	0.000243	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—lung cancer	2.73e-05	0.000243	CcSEcCtD
Losartan—Diarrhoea—Methotrexate—lung cancer	2.73e-05	0.000243	CcSEcCtD
Losartan—Dizziness—Methotrexate—lung cancer	2.64e-05	0.000235	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—lung cancer	2.54e-05	0.000227	CcSEcCtD
Losartan—Vomiting—Methotrexate—lung cancer	2.54e-05	0.000226	CcSEcCtD
Losartan—Rash—Methotrexate—lung cancer	2.51e-05	0.000224	CcSEcCtD
Losartan—Dermatitis—Methotrexate—lung cancer	2.51e-05	0.000224	CcSEcCtD
Losartan—Headache—Methotrexate—lung cancer	2.5e-05	0.000223	CcSEcCtD
Losartan—Asthenia—Doxorubicin—lung cancer	2.48e-05	0.000221	CcSEcCtD
Losartan—Pruritus—Doxorubicin—lung cancer	2.44e-05	0.000218	CcSEcCtD
Losartan—Nausea—Methotrexate—lung cancer	2.37e-05	0.000211	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—lung cancer	2.36e-05	0.00021	CcSEcCtD
Losartan—Dizziness—Doxorubicin—lung cancer	2.28e-05	0.000203	CcSEcCtD
Losartan—Vomiting—Doxorubicin—lung cancer	2.2e-05	0.000196	CcSEcCtD
Losartan—Rash—Doxorubicin—lung cancer	2.18e-05	0.000194	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—lung cancer	2.18e-05	0.000194	CcSEcCtD
Losartan—Headache—Doxorubicin—lung cancer	2.16e-05	0.000193	CcSEcCtD
Losartan—Nausea—Doxorubicin—lung cancer	2.05e-05	0.000183	CcSEcCtD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.59e-06	2.43e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTA2—lung cancer	2.59e-06	2.43e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NQO1—lung cancer	2.59e-06	2.42e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CD—lung cancer	2.58e-06	2.42e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SRC—lung cancer	2.57e-06	2.41e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.57e-06	2.41e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HPGDS—lung cancer	2.56e-06	2.4e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ENO2—lung cancer	2.56e-06	2.4e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—lung cancer	2.55e-06	2.39e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.55e-06	2.39e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—SRC—lung cancer	2.54e-06	2.39e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.51e-06	2.36e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.51e-06	2.35e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—lung cancer	2.51e-06	2.35e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTA1—lung cancer	2.5e-06	2.34e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.5e-06	2.34e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—EP300—lung cancer	2.49e-06	2.34e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP1A1—lung cancer	2.49e-06	2.33e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTT1—lung cancer	2.48e-06	2.33e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—lung cancer	2.48e-06	2.33e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—lung cancer	2.48e-06	2.32e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRAS—lung cancer	2.48e-06	2.32e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTP1—lung cancer	2.48e-06	2.32e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCC3—lung cancer	2.47e-06	2.32e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ERCC2—lung cancer	2.47e-06	2.32e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	2.47e-06	2.31e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTP1—lung cancer	2.46e-06	2.31e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CB—lung cancer	2.46e-06	2.31e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP2A6—lung cancer	2.46e-06	2.3e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GCLC—lung cancer	2.46e-06	2.3e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—NRAS—lung cancer	2.45e-06	2.29e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.45e-06	2.29e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP2E1—lung cancer	2.44e-06	2.29e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—lung cancer	2.44e-06	2.28e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NQO1—lung cancer	2.42e-06	2.27e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CAT—lung cancer	2.41e-06	2.26e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CAT—lung cancer	2.4e-06	2.25e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.4e-06	2.25e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKR1C1—lung cancer	2.39e-06	2.25e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—STK11—lung cancer	2.39e-06	2.24e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.38e-06	2.23e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK3—lung cancer	2.37e-06	2.22e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.37e-06	2.22e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.34e-06	2.2e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK3—lung cancer	2.34e-06	2.2e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCB1—lung cancer	2.34e-06	2.2e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—STK11—lung cancer	2.33e-06	2.19e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCB1—lung cancer	2.33e-06	2.19e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ENO1—lung cancer	2.33e-06	2.18e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—UGT1A1—lung cancer	2.32e-06	2.18e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.32e-06	2.17e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—lung cancer	2.31e-06	2.16e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TYMS—lung cancer	2.3e-06	2.16e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.29e-06	2.15e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—TYMS—lung cancer	2.29e-06	2.15e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTM1—lung cancer	2.28e-06	2.13e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTM1—lung cancer	2.26e-06	2.12e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—lung cancer	2.26e-06	2.12e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CB—lung cancer	2.25e-06	2.11e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.24e-06	2.1e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GNG11—lung cancer	2.24e-06	2.1e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—lung cancer	2.23e-06	2.09e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTP1—lung cancer	2.21e-06	2.07e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—STK11—lung cancer	2.18e-06	2.04e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—lung cancer	2.17e-06	2.03e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTP1—lung cancer	2.16e-06	2.02e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP1A1—lung cancer	2.16e-06	2.02e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CAT—lung cancer	2.15e-06	2.02e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP1A1—lung cancer	2.14e-06	2.01e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ERCC2—lung cancer	2.14e-06	2.01e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.14e-06	2e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—APOA1—lung cancer	2.14e-06	2e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALDOA—lung cancer	2.13e-06	2e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—lung cancer	2.13e-06	2e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ERCC2—lung cancer	2.13e-06	1.99e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTEN—lung cancer	2.12e-06	1.99e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—lung cancer	2.11e-06	1.98e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CAT—lung cancer	2.1e-06	1.97e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCB1—lung cancer	2.09e-06	1.96e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP2E1—lung cancer	2.09e-06	1.96e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NCOA3—lung cancer	2.07e-06	1.94e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NQO1—lung cancer	2.06e-06	1.94e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TYMS—lung cancer	2.05e-06	1.93e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—lung cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTM1—lung cancer	2.03e-06	1.9e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—EP300—lung cancer	2.03e-06	1.9e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.02e-06	1.9e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ADCY1—lung cancer	2.02e-06	1.89e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCG2—lung cancer	2.02e-06	1.89e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTP1—lung cancer	2.01e-06	1.89e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TYMS—lung cancer	2.01e-06	1.88e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2e-06	1.88e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTM1—lung cancer	1.98e-06	1.86e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ENO2—lung cancer	1.98e-06	1.85e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HPGDS—lung cancer	1.98e-06	1.85e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.96e-06	1.84e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CAT—lung cancer	1.96e-06	1.84e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—lung cancer	1.96e-06	1.84e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CG—lung cancer	1.95e-06	1.83e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.95e-06	1.83e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTEN—lung cancer	1.95e-06	1.83e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—lung cancer	1.94e-06	1.81e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP1A1—lung cancer	1.93e-06	1.81e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTT1—lung cancer	1.92e-06	1.8e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ERCC2—lung cancer	1.91e-06	1.79e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCB1—lung cancer	1.91e-06	1.79e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GCLC—lung cancer	1.9e-06	1.78e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2A6—lung cancer	1.9e-06	1.78e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—lung cancer	1.89e-06	1.78e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP1A1—lung cancer	1.88e-06	1.76e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TYMS—lung cancer	1.87e-06	1.76e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—lung cancer	1.87e-06	1.76e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ERCC2—lung cancer	1.86e-06	1.75e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—STK11—lung cancer	1.86e-06	1.74e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—POMC—lung cancer	1.86e-06	1.74e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—EP300—lung cancer	1.86e-06	1.74e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTM1—lung cancer	1.85e-06	1.74e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—APOA1—lung cancer	1.85e-06	1.74e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—lung cancer	1.84e-06	1.73e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—APOA1—lung cancer	1.84e-06	1.73e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—lung cancer	1.81e-06	1.7e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CREBBP—lung cancer	1.81e-06	1.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ENO1—lung cancer	1.8e-06	1.68e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—lung cancer	1.79e-06	1.68e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.77e-06	1.66e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—lung cancer	1.77e-06	1.66e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.76e-06	1.65e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1A1—lung cancer	1.76e-06	1.65e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.75e-06	1.64e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ERCC2—lung cancer	1.74e-06	1.63e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—lung cancer	1.73e-06	1.63e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTP1—lung cancer	1.72e-06	1.61e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CD—lung cancer	1.71e-06	1.61e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—lung cancer	1.69e-06	1.59e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CG—lung cancer	1.69e-06	1.58e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CG—lung cancer	1.68e-06	1.58e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CAT—lung cancer	1.68e-06	1.57e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—lung cancer	1.67e-06	1.57e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.67e-06	1.56e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APOA1—lung cancer	1.65e-06	1.55e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCB1—lung cancer	1.63e-06	1.53e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APOA1—lung cancer	1.61e-06	1.51e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2E1—lung cancer	1.61e-06	1.51e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—POMC—lung cancer	1.61e-06	1.51e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TYMS—lung cancer	1.6e-06	1.5e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—lung cancer	1.6e-06	1.5e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—POMC—lung cancer	1.6e-06	1.5e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NQO1—lung cancer	1.59e-06	1.49e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTM1—lung cancer	1.58e-06	1.48e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.58e-06	1.48e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—lung cancer	1.58e-06	1.48e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CREBBP—lung cancer	1.57e-06	1.47e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CREBBP—lung cancer	1.56e-06	1.46e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CG—lung cancer	1.51e-06	1.41e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—lung cancer	1.51e-06	1.41e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOA1—lung cancer	1.51e-06	1.41e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP1A1—lung cancer	1.5e-06	1.41e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—lung cancer	1.5e-06	1.41e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CB—lung cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ERCC2—lung cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CD—lung cancer	1.49e-06	1.39e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—lung cancer	1.48e-06	1.39e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CD—lung cancer	1.48e-06	1.38e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CG—lung cancer	1.47e-06	1.38e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—lung cancer	1.47e-06	1.37e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.44e-06	1.35e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—STK11—lung cancer	1.44e-06	1.35e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—POMC—lung cancer	1.44e-06	1.35e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—POMC—lung cancer	1.4e-06	1.31e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CREBBP—lung cancer	1.4e-06	1.31e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CG—lung cancer	1.37e-06	1.29e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—lung cancer	1.37e-06	1.29e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CREBBP—lung cancer	1.36e-06	1.28e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTP1—lung cancer	1.33e-06	1.25e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CD—lung cancer	1.33e-06	1.24e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—POMC—lung cancer	1.31e-06	1.23e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—lung cancer	1.31e-06	1.23e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CB—lung cancer	1.29e-06	1.21e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CD—lung cancer	1.29e-06	1.21e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CAT—lung cancer	1.29e-06	1.21e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTEN—lung cancer	1.29e-06	1.21e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CB—lung cancer	1.29e-06	1.21e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOA1—lung cancer	1.29e-06	1.21e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—lung cancer	1.28e-06	1.2e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—lung cancer	1.28e-06	1.2e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—lung cancer	1.28e-06	1.2e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CREBBP—lung cancer	1.27e-06	1.2e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCB1—lung cancer	1.26e-06	1.18e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TYMS—lung cancer	1.24e-06	1.16e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.23e-06	1.16e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—EP300—lung cancer	1.23e-06	1.15e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—lung cancer	1.22e-06	1.15e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTM1—lung cancer	1.22e-06	1.15e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CD—lung cancer	1.21e-06	1.13e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—lung cancer	1.19e-06	1.12e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CG—lung cancer	1.17e-06	1.1e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1A1—lung cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CB—lung cancer	1.16e-06	1.08e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ERCC2—lung cancer	1.15e-06	1.08e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—lung cancer	1.14e-06	1.07e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CB—lung cancer	1.13e-06	1.06e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—lung cancer	1.12e-06	1.05e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTEN—lung cancer	1.12e-06	1.05e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—POMC—lung cancer	1.12e-06	1.05e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—lung cancer	1.12e-06	1.05e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTEN—lung cancer	1.11e-06	1.04e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CREBBP—lung cancer	1.09e-06	1.02e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—EP300—lung cancer	1.07e-06	1e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—EP300—lung cancer	1.06e-06	9.95e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CB—lung cancer	1.05e-06	9.88e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—lung cancer	1.04e-06	9.79e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CD—lung cancer	1.03e-06	9.69e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—lung cancer	1.02e-06	9.56e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTEN—lung cancer	9.98e-07	9.36e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOA1—lung cancer	9.93e-07	9.31e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTEN—lung cancer	9.74e-07	9.14e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—EP300—lung cancer	9.52e-07	8.93e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—EP300—lung cancer	9.29e-07	8.71e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—lung cancer	9.11e-07	8.54e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTEN—lung cancer	9.1e-07	8.54e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CG—lung cancer	9.07e-07	8.5e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CB—lung cancer	9e-07	8.44e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—lung cancer	8.92e-07	8.36e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—EP300—lung cancer	8.68e-07	8.14e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—POMC—lung cancer	8.63e-07	8.09e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CREBBP—lung cancer	8.41e-07	7.88e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CD—lung cancer	7.97e-07	7.47e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—lung cancer	7.89e-07	7.4e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—lung cancer	7.87e-07	7.38e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—lung cancer	7.85e-07	7.36e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTEN—lung cancer	7.78e-07	7.29e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—lung cancer	7.44e-07	6.98e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—EP300—lung cancer	7.42e-07	6.96e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—lung cancer	7.04e-07	6.6e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CB—lung cancer	6.95e-07	6.52e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—lung cancer	6.88e-07	6.46e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—lung cancer	6.87e-07	6.45e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—lung cancer	6.45e-07	6.04e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—lung cancer	6.42e-07	6.02e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—lung cancer	6.41e-07	6.01e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTEN—lung cancer	6e-07	5.63e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—lung cancer	5.75e-07	5.4e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—EP300—lung cancer	5.73e-07	5.37e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—lung cancer	5.62e-07	5.27e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—lung cancer	5.49e-07	5.15e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—lung cancer	5.25e-07	4.92e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—lung cancer	4.48e-07	4.2e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—lung cancer	4.24e-07	3.97e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—lung cancer	3.46e-07	3.24e-06	CbGpPWpGaD
